Literature DB >> 856004

Effect of ethambutol on the viable cell count in Mycobacterium smegmatis.

J O Kilburn, J Greenberg.   

Abstract

Soon after a strain of Mycobacterium smegmatis was exposed to ethambutol (EMB), the number of viable cells increased dramatically above the number in a drug-free control. This rapid rise did not occur when the culture was maintained at 4 degrees C instead of 37 degrees C, when an EMB-resistant mutant was used, when auxotrophs were exposed in medium lacking nutrients essential for growth, nor when the levo form of EMB was used. EMB caused no increase in deoxyribonucleic acid synthesis, nor in septum formation of dividing cells. Treated cells changed morphologically, resulting in a lower surface area-to-volume ratio. Whereas EMB did not eliminate cell clusters, the cluster size decreased markedly as detected by filtration and Coulter counter measurements. We concluded that EMB causes a reduced surface-to-volume ratio, leading to reduced cell cohesion and a consequent reduction in cluster size, reflected in an increase in colony-forming units.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856004      PMCID: PMC352017          DOI: 10.1128/AAC.11.3.534

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  A simple membrane fractionation method for determining the distribution of radioactivity in chemical fractions of Bacillus cereus.

Authors:  D B ROODYN; H G MANDEL
Journal:  Biochim Biophys Acta       Date:  1960-06-17

2.  Mode of action of ethambutol.

Authors:  M FORBES; N A KUCK; E A PEETS
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

3.  EFFECT OF ETHAMBUTOL ON CYTOLOGY OF MYCOBACTERIUM SMEGMATIS.

Authors:  G R GALE; H H MCLAIN
Journal:  J Bacteriol       Date:  1963-10       Impact factor: 3.490

  3 in total
  9 in total

Review 1.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

2.  Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis.

Authors:  K Takayama; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis.

Authors:  J O Kilburn; K Takayama; E L Armstrong; J Greenberg
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare.

Authors:  B G Yangco; E A Eikman; D A Solomon; S C Deresinski; J A Madden
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

5.  The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis.

Authors:  R Goude; A G Amin; D Chatterjee; T Parish
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

6.  Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis.

Authors:  K Takayama; E L Armstrong; K A Kunugi; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope.

Authors:  L Deng; K Mikusová; K G Robuck; M Scherman; P J Brennan; M R McNeil
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

8.  Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis.

Authors:  J O Kilburn; K Takayama
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

9.  The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria.

Authors:  Karin Schubert; Boris Sieger; Fabian Meyer; Giacomo Giacomelli; Kati Böhm; Angela Rieblinger; Laura Lindenthal; Nadja Sachs; Gerhard Wanner; Marc Bramkamp
Journal:  mBio       Date:  2017-02-07       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.